8-NH2-boldine, an antagonist of α1A and α1B adrenoceptors without affinity for the α1D subtype: Structural requirements for aporphines at α1- adrenoceptor subtypes

Planta Medica

Volumn 71, Issue 10, 2005, Pages 897-903

  Ivorra, M Dolores ^a   Valiente, Miguel ^a,c   Martĩnez, Sonia ^a   Madrero, Yolanda ^a   Noguera, M Antonia ^a   Cassels, Bruce K ^b   Sobarzo, Eduardo M ^b   D'Ocon, Pilar ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF CHILE   (Chile)

^c CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

Aorta; Aporphines; Cerebral cortex; Cyclic nucleotide phosphodiesterases; Human cloned 1 adrenoceptor subtypes; Tail artery

Indexed keywords

2,10,11 APORPHINETRIOL; 3 BROMOGLAUCINE; 3 IODOBOLDINE; 3,8 DIBROMOBOLDINE; 3,8 DICHLOROBOLDINE; 3,8 DICHLOROGLAUCINE; 8 AMINOBOLDINE; 8 NITROXYBOLDINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; APOCODEINE; APOMORPHINE; APORPHINE DERIVATIVE; BOLDINE; BULBOCAPNINE; DILTIAZEM; GLAUCINE; INOSITOL PHOSPHATE; IODINE 125; NORADRENALIN; NORAPOMORPHINE; PRAZOSIN; PROPYLNORAPOMORPHINE; UNCLASSIFIED DRUG; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;

ANIMAL CELL; AORTA CONSTRICTION; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN CORTEX; DRUG RECEPTOR BINDING; DRUG STRUCTURE; FEMALE; FIBROBLAST; MOLECULAR CLONING; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION; ANIMAL; ARTERY; BINDING COMPETITION; DRUG ANTAGONISM; DRUG EFFECT; MEDICINAL PLANT; MUSCLE CONTRACTION; PHYSIOLOGY; PHYTOTHERAPY; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AORTA, THORACIC; APORPHINES; ARTERIES; BINDING, COMPETITIVE; CEREBRAL CORTEX; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PHYTOTHERAPY; PLANTS, MEDICINAL; RATS; RECEPTORS, ADRENERGIC, ALPHA-1; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 27844444765     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-871281     Document Type: Article

References (24)

1. 1-adrenoceptors: consensus update. Pharmacol Rev 1995; 47: 267-70
2. 1A-adrenoceptor subtype. Br J Pharmacol 1996; 119: 1563-8
3. 1A-adrenoceptors in rat cerebral cortex. Life Sci 1999; 64: 1205-14
4. 1 adrenergic receptors: sequence corrections and direct comparison with other species homologues. J Pharmacol ExpTher 1995; 272: 134-42
5. Lachnit WG, Train AM, Clarke DE, Ford APDW. Pharmacological characterization of an alpha 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat. Br J Pharmacol 1997; 120: 819-26
6. 1A-adrenoceptors in rat aorta. J Pharmacol Exp Ther 2000; 295: 810-7
7. 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br J Pharmacol 1995; 115: 981-6
8. 1D-adrenoceptor to the contraction of vascular smooth muscle. J Pharmacol Exp Ther 1995; 275: 1583-9
9. 1D subtype. Eur J Pharmacol 1996; 297: 241-8
10. 1-adrenoceptors mediating contractions of rabbit isolated ear artery: comparison with rat isolated thoracic aorta. Br J Pharmacol 1997; 120: 247-58
11. 1- adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta mesenteric artery and pulmonary artery. Br J Pharmacol 1997; 122: 849-58
12. 1-Adrenoceptor subtypes in rat aorta and mesenteric small arteries are preserved during left ventricular dysfunction post-myocardial infarction. Cardiovasc Res 1997; 33: 706-13
13. 1-adrenoceptor subtypes in vascular tissues using different experimental approaches: a comparative study. Br J Pharmacol 2003; 138: 359-68
14. 1- adrenergic receptors and benzothiazepine receptor site at the calcium channel. Br J Pharmacol 2003; 106: 387-94
15. Arunlakshana O, Schild HO. Some quantitative uses of drug antagonists. Br J Pharmacol 1959; 14: 48-58
16. Asencio M, Cassels BK, Speisky H. The methylation of boldine with diazomethane. J Chil Chem Soc 1993; 38: 331-4
17. Sobarzo-Sánchez E M, Arbaoui J, Protais P, Cassels B K. Halogenated boldine derivatives with enhanced monoamine receptor selectivity. J Nat Prod 2000; 63: 480-4
18. Sobarzo-Sánchez E, Cassels B K, Saitz-Barría C, Jullian C. Oxazine- and oxazole-fused derivatives of the alkaloid boldine and their complete structural and spectral assignment by HMQC and HMBC experiments. Magn Reson Chem 2001; 39: 361-6
19. Indra B, Matsunaga K, Hoshino O, Suzuki M, Ogasawara H, Ohizumi Y. Structure-activity relationship studies with (+/-)-nantenine derivatives for alpha1-adrenoceptor antagonist activity. Eur J Pharmacol 2002; 437: 173-8
20. Schaus JM, Titus RD, Foreman MM, Mason NR, Truex LLJ. Aporphines as antagonists of dopamine D-1 receptors. Med Chem 1990; 33: 600-7
21. Baldessarini RJ, Kula NS, Zong R, Neumeyer JL. Receptor affinities of aporphine enantiomers in rat brain tissue. Eur J Pharmacol 1994; 254: 199-203
22. Yocca FD, Hyslop DK, Smith DW, Maayani S. BMY 7378 a buspirone analog with high affinity selectivity and low intrinsic activity at the 5-HT1A receptor in rat and guinea pig hippocampal membranes. Eur J Pharmacol 1987; 37: 293-4
23. Sharp T, Backus LI, Hjorth S, Bramwell SR, Grahame-Smith DG. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist BMY 7378. Eur J Pharmacol 1990; 176: 331-40
24. 1D-subtype. J Pharmacol Exp Ther 1996; 278: 136-44